Increased access to genomic testing can help fulfill the promise of making precision medicine accessible to all, but the upfront investment required for institutions to start their own sequencing labs remains a barrier. This challenge can be overcome by using sequencing service.
By leveraging expertly curated evidence, powered by JAX-CKB, and SOPHiA GENETICS’ patented algorithms through the SOPHiA DDM platform, users can then use OncoPortal™ Plus to accurately identify clinical associations and actionable biomarker profiles.
The President acknowledged that the US still has much further to come in advancing data-driven initiatives and that many Americans sadly do not realize the struggle of seeking answers during the cancer diagnostic journey until it’s too late.
2021 has been a big year for SOPHiA GENETICS. Here’s a recap of some of the major highlights…
Radiomics maximizes upon information that’s already being collected. The difference is how that info is used.
About half of all breast cancer patients develop the disease outside of the period of ages 50-69 and could greatly benefit from earlier detection. Today, we know that age alone is not enough to accurately estimate breast cancer risk.
Think of it like trying to find a treasure buried on a beach. It would be a lot easier to use a metal detector than to pick through each grain of sand.
Humans being replaced by computers is a common theme in TV shows, movies, books and more. But unlike what we often see in fiction, artificial intelligence (AI) doesn’t replace the human factor in medicine.
On September 1st, we celebrated the grand opening of our new Swiss premises in Rolle, on the beautiful coast of Lake Geneva.
The medical research community has been buried in data since well before the global COVID-19 pandemic. How they’re now managing the extreme additional influx of SARS-CoV-2 data determines the outcomes of a lab’s overall research capabilities.
While we all get swept up by the seasonal fun in the sun, it’s easy to forget about that range of invisible, yet harmful UV rays.
To measure results from one individual against those of a control group and those with similar genomic profiles, data analysis must be unconditionally repeatable.
